{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:43:55Z","timestamp":1784684635293,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T00:00:00Z","timestamp":1487721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1157021"],"award-info":[{"award-number":["OPP1157021"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.02.017","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T13:33:26Z","timestamp":1487856806000},"page":"1579-1585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Vaccines: Shaping global health"],"prefix":"10.1016","volume":"35","author":[{"given":"Sonia","family":"Pagliusi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chia","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Lobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Datla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra","family":"Suhardono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajinder","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Tippoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.02.017_b0005","unstructured":"WHO statement on the first meeting of the International Health Regulations (2005) (IHR2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations. Media centre of World Health Organization. 1 February 2016. Available at: <http:\/\/www.who.int\/mediacentre\/news\/statements\/2016\/1st-emergency-committee-zika\/en\/>."},{"key":"10.1016\/j.vaccine.2017.02.017_b0010","unstructured":"Ebola virus disease in Guinea. Outbreak news. Regional office for Africa of World Health Organization. 23 March 2014. Available at: <http:\/\/www.afro.who.int\/en\/disease-outbreaks\/outbreak-news\/4063-ebola-virus-disease-in-guinea.html>."},{"issue":"50","key":"10.1016\/j.vaccine.2017.02.017_b0015","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1016\/j.vaccine.2015.09.105","article-title":"Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine","volume":"33","author":"Precioso","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.017_b0020","unstructured":"La regi\u00f3n de las Am\u00e9ricas es declarada libre de sarampi\u00f3n. PAHO\/WHO Regional office for the Americas. Washington, 27 September 2016. Available at: <http:\/\/www.paho.org\/hq\/index.php?option=com_content&view=article&id=12528%3Aregion-americas-declared-free-measles>."},{"key":"10.1016\/j.vaccine.2017.02.017_b0025","unstructured":"Gavi, The Vaccine Alliance. Results & Evidence. Gavi Progress Report. Gavi Progress Report 2015. Available at: <http:\/\/gaviprogressreport.org\/2015\/#page=11>."},{"key":"10.1016\/j.vaccine.2017.02.017_b0030","doi-asserted-by":"crossref","unstructured":"Cohen J. Science 2016, Sep 2nd, commentary. New vaccine coalition aims to ward off epidemics. Available at: <http:\/\/www.sciencemag.org\/news\/2016\/09\/new-vaccine-coalition-aims-ward-epidemics>.","DOI":"10.1126\/science.aah7263"},{"issue":"6","key":"10.1016\/j.vaccine.2017.02.017_b0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nrd3405","article-title":"The productivity crisis in pharmaceutical R&D","volume":"10","author":"Pammolli","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2017.02.017_b0040","unstructured":"Good regulatory practices: guidelines for national regulatory authorities for medical products. WHO Working document QAS\/16.686. October 2016, Draft for comment. Prepared by EMP\/RSS. Available at: <http:\/\/www.who.int\/medicines\/areas\/quality_safety\/quality_assurance\/GoodRegulatory_PracticesPublicConsult.pdf?ua=1>."},{"key":"10.1016\/j.vaccine.2017.02.017_b0045","unstructured":"Regional Platform on Access and Innovation for Health Technologies. PRAIS.PAHO\/WHO Regional office for the Americas. Available at: <http:\/\/prais.paho.org\/>."},{"issue":"30","key":"10.1016\/j.vaccine.2017.02.017_b0050","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.vaccine.2016.03.112","article-title":"Human anthelminthic vaccines: Rationale and challenges","volume":"34","author":"Hotez","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.017_b0055","unstructured":"Access to Vaccines Index. Available at: <https:\/\/accesstomedicinefoundation.org\/news\/access-to-vaccines-index-the-data-is-in-analysis-can-begin\/#about-atvi>."},{"key":"10.1016\/j.vaccine.2017.02.017_b0060","unstructured":"WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use. GAP III. WHO\/POLIO\/15.05. Global Polio Eradication Initiative. Available at: <http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/09\/GAPIII_2014.pdf>."},{"key":"10.1016\/j.vaccine.2017.02.017_b0065","unstructured":"GAP III Containment Certification Scheme (CCS). Polio Today. Global Polio Eradication Initiative. 2016. Available at: <http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/10\/CCS.pdf>."},{"key":"10.1016\/j.vaccine.2017.02.017_b0070","unstructured":"Replacing trivalent OPV with bivalent OPV. Vaccines and diseases. Immunization, Vaccines and Biologicals. WHO. Available at: <http:\/\/www.who.int\/immunization\/diseases\/poliomyelitis\/endgame_objective2\/oral_polio_vaccine\/en\/>."},{"key":"10.1016\/j.vaccine.2017.02.017_b0075","unstructured":"Meeting of the Strategic Advisory Group of Experts on Immunization, October 2016 \u2013 conclusions and recommendations. Weekly Epidemiological Record, 2 December 2016, vol. 91, pp. 561\u2013584. Programmes and projects. WHO. Available at: <http:\/\/apps.who.int\/iris\/bitstream\/10665\/251810\/1\/WER9148.pdf?ua=1>."},{"key":"10.1016\/j.vaccine.2017.02.017_b0080","unstructured":"Inactivated Polio Vaccine: Supply Update. UNICEF Supply Division. UNICEF. September 2016. Available at: <https:\/\/www.unicef.org\/supply\/files\/Inactivated_Polio_Vaccine_(IPV)_-_september_2016.pdf>."},{"key":"10.1016\/j.vaccine.2017.02.017_b0085","unstructured":"Preparing for the withdrawal of all oral polio vaccines (OPVs): replacing trivalent OPV with bivalent OPV. Frequently Asked Questions. February 2015. EPI. Global Polio Eradication Initiative. Available at: <http:\/\/www.who.int\/immunization\/diseases\/poliomyelitis\/endgame_objective2\/oral_polio_vaccine\/OPVswitch-overviewFAQs-Feb2015.pdf>."},{"issue":"37","key":"10.1016\/j.vaccine.2017.02.017_b0090","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1016\/j.vaccine.2015.03.062","article-title":"Opportunities and challenges in delivering influenza vaccine by microneedle patch","volume":"33","author":"Jacoby","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.017_b0095","unstructured":"GPEI. Global Polio Eradication Initiative. Polio Now. Available at: <http:\/\/polioeradication.org\/polio-today\/polio-now\/>."},{"key":"10.1016\/j.vaccine.2017.02.017_b0100","unstructured":"Cessation of use of trivalent oral polio vaccine and introduction of inactivated poliovirus vaccine worldwide, 2016. Weekly epidemiological record. 9 September 2016, vol. 91, pp. 421\u2013432. Programmes and projects. WHO. Available at: <http:\/\/apps.who.int\/iris\/bitstream\/10665\/250045\/1\/WER9136_37.pdf>."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T11:07:39Z","timestamp":1717240059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17301986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X17301986"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines: Shaping global health","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}